Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warner Huh

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Gynecologic Oncology|May 11, 2020
Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisisBhavana Pothuri, Angeles Alvarez Secord, Deborah K Armstrong, et al.
Journal of Lower Genital Tract Disease|June 28, 2022
Risk-Based Cervical Consensus Guidelines: Methods to Determine Management if Less Than 5 Years of Data Are AvailableDidem Egemen, Rebecca B Perkins, Megan A Clarke, et al.
Gynecologic Oncology|January 12, 2020
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)Alessandro D Santin, Wei Deng, Michael Frumovitz, et al.
Journal of Lower Genital Tract Disease|March 6, 2024
Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and ProcessNicolas Wentzensen, Francisco Garcia, Megan A Clarke, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 10, 2013
Clinical trial experience with prophylactic human papillomavirus 6/11/16/18 vaccine in young black womenLiana R Clark, Evan R Myers, Warner Huh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγRuey-Shyang Soong, Liwen Song, Janson Trieu, et al.
Gynecologic Oncology|June 26, 2020
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, part IRachel C Sisodia, Summer B Dewdney, Amanda N Fader, et al.
Gynecologic Oncology|June 26, 2020
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, Part IIRachel C Sisodia, Summer B Dewdney, Amanda N Fader, et al.
Obstetrics and Gynecology|November 7, 2024
Optimization of Timing for Risk-Reducing Salpingectomy and OophorectomyKathryn P Pennington, Stephanie L Pugh, Warner Huh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 8, 2026
Efficacy of topical treatments for high-risk human papillomavirus in preventing CIN II+ lesions: a systematic reviewRene Pareja, Núria Agustí, Santiago Vieira, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Gynecologic Oncology|May 11, 2020
Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisisBhavana Pothuri, Angeles Alvarez Secord, Deborah K Armstrong, et al.
Journal of Lower Genital Tract Disease|June 28, 2022
Risk-Based Cervical Consensus Guidelines: Methods to Determine Management if Less Than 5 Years of Data Are AvailableDidem Egemen, Rebecca B Perkins, Megan A Clarke, et al.
Gynecologic Oncology|January 12, 2020
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)Alessandro D Santin, Wei Deng, Michael Frumovitz, et al.
Journal of Lower Genital Tract Disease|March 6, 2024
Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and ProcessNicolas Wentzensen, Francisco Garcia, Megan A Clarke, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 10, 2013
Clinical trial experience with prophylactic human papillomavirus 6/11/16/18 vaccine in young black womenLiana R Clark, Evan R Myers, Warner Huh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγRuey-Shyang Soong, Liwen Song, Janson Trieu, et al.
Gynecologic Oncology|June 26, 2020
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, part IRachel C Sisodia, Summer B Dewdney, Amanda N Fader, et al.
Gynecologic Oncology|June 26, 2020
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, Part IIRachel C Sisodia, Summer B Dewdney, Amanda N Fader, et al.
Obstetrics and Gynecology|November 7, 2024
Optimization of Timing for Risk-Reducing Salpingectomy and OophorectomyKathryn P Pennington, Stephanie L Pugh, Warner Huh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 8, 2026
Efficacy of topical treatments for high-risk human papillomavirus in preventing CIN II+ lesions: a systematic reviewRene Pareja, Núria Agustí, Santiago Vieira, et al.
Pageof 4